In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial has shown that a novel agent can protect against the most common viral infection that patients face after transplantation.
In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial has shown that a novel agent can protect against the most common viral infection that patients face after transplantation.